Radiation Oncologist at University Hospital Zurich @Unispital_USZ | Professor at University of Zurich @UZH_ch | @ESTRO_RT President
USZ Zurich
Joined February 2018
- Tweets2.3K
- Following271
- Followers5.9K
- Likes5K
Matthias Guckenberger retweeted
Dear @ESTRO_RT and @Mat_Guc , thank you for letting this crew help you close out another great year! We hope we gave everyone in attendance some food for thought and inspiration for the trip home. And to the Closing Team: mission accomplished. 💫🍾 See you in Milan next year! – at Stockholm, Sweden
Matthias Guckenberger retweeted
🎥 In this #ESTRO26 opening interview, Matthias Guckenberger, President of ESTRO, sets the tone for the days ahead in Stockholm. What does “Innovating Radiation Oncology, Together” really mean in practice? Find out in the video. #radonc @oncoalert @vjoncology @Mat_Guc
Matthias Guckenberger retweeted
ASTRO is deeply disturbed by the inaccurate, inappropriate, and irresponsible NBC News piece on IORT. We feel this story harms care for breast cancer patients & have strongly rebutted it through our Breast Cancer Resource Panel & a letter from ASTRO CEO, Vivek S Kavadi, MD to NBC News.
Read each here:
Breast Resource Panel Statement
ow.ly/aicz50X9ty1
Letter to NBC News from Dr. Vivek S. Kavadi
ow.ly/Hvy550X9txZ
Matthias Guckenberger retweeted
Important prediction modeling for patients with oligometastatic cancer based on distant metastases velocity (DMV). Great collaboration and proud to contribute our @Sunnybrook data. No doubt that #SBRT is critical to advancing outcomes for these patients. pubmed.ncbi.nlm.nih.gov/4087…
Matthias Guckenberger retweeted
Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !
Matthias Guckenberger retweeted
🎥 Exclusive interview this morning at #ESTRO25:
We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology.
Don’t miss his insights ⬇️
#Radiotherapy #CancerResearch @Mat_Guc
Matthias Guckenberger retweeted
Greetings from #ESTRO25 and a wam welcome to #APCCC26 in Lugano 🇨🇭
@Silke_Gillessen @BarbaraJereczek @piet_ost @ZilliThomas @GiulioFrancoli1 @Mat_Guc @VedangMurthy
@OncoAlert 🚨
Matthias Guckenberger retweeted
SBRT + 💊 in oligomets:
🧍♂️2294 pts | 🫁, breast, prostate, colorectal
⚠️Grade 3+ AEs: 1.5%
✅ SBRT Safe with systemic tx!
#SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
Matthias Guckenberger retweeted
Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer
“What if radiation oncology was a start up”
Highlights the 5’s:
Collaborate
Communicate
Learn from every Customer
Cost Efficiency
Culture
Matthias Guckenberger retweeted
📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from @UofT for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! @ldawsonmd #lcsm
Matthias Guckenberger retweeted
🎉We’re excited to announce that the first patient has been randomised in the SPRINT study!
The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad.
👉 project.eortc.org/e2-radiate…
#E2RADIatE #OligoCare @piet_ost @Mat_Guc
Matthias Guckenberger retweeted
🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna!
📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall
👉 Full interview here: bit.ly/4ifJd75
#Radonc #OncologyInnovation #ESTROAwards
Matthias Guckenberger retweeted
@EORTC launches first European TwiCs within OligoCare randomising single vs multifraction SBRT for oligomets! @Mat_Guc
🎉 We are excited to announce that the first two centres have been activated for the SPRINT clinical trial, the first pan-European Trial within Cohorts (TwiCs), leveraging real-world data from the #E2RADIatE #OligoCare cohort.
Find out more: project.eortc.org/e2-radiate…
#SPRINTtrial
Matthias Guckenberger retweeted
🚨 ESTRO Board Elections – Reminder!
Voting opens soon (20 March–20 April)! If you wish to vote for the new Clinical and Physics representatives, you must be an ESTRO member in both 2024 & 2025.
⌛ Renew your 2025 membership by 10 March to be eligible to vote, only 1 week left!
Matthias Guckenberger retweeted
We're back! @PeterMacRadOnc @PeterMacCC - Nov 14th and 15th.... save the date!!!! #radonc #radiotherapy
Matthias Guckenberger retweeted
Understanding the Disruptive Potential of MDT in Metastatic Prostate Cancer Treatment, Exploring Hypotheses for Future Studies dailynews.ascopubs.org/do/un…
#ASCODailyNews
@ASCO
@GiuliaMarvaso84
@FMastroleoMD
@piet_ost
@ChadTangMD
SimonaBorghesi
Matthias Guckenberger retweeted
@ISRSy guideline for SBRT to non spine bone metastases is published as pre proof in @RO_GreenJournal. Thanks to Dr. Tim Nguyen from London, Ontario, for leading this and @alison_tree from Royal Marsden, UK, and the guideline committee of global experts.
